Physician profile
Scott B Rosenfeld
NPI 1508063942
$31,270.11
in general payments reported to CMS, 2019-2025
9 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,272 · 2020: $175 · 2021: $3,264 · 2022: $3,373 · 2023: $73.55 · 2024: $23K · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $1,568 · Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,650.00 |
| Travel and Lodging | $1,567.65 |
| Food and Beverage | $969.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $25,438.68 | 2022-2024 | |
| Medinc of Texas | $3,156.69 | 2019-2025 | |
| Arthrex, INC. | $1,216.00 | 2021 | |
| Stryker Corporation | $856.12 | 2020-2025 | Serrato, Everest Spinal System, Xia 3 |
| Depuy Synthes Sales INC. | $252.65 | 2021-2022 | |
| Vb Spine LLC | $144.04 | 2025 | Xia 3 |
| Smith+Nephew, INC. | $130.28 | 2019 | |
| Medacta USA, INC. | $55.99 | 2023-2025 | Mecta |
| Medtronic USA, INC. | $19.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Rosenfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.